Description
The
global wearable injectors market is anticipated to reach USD 11.3 billion by
2025, according to a new report by Grand View Research, Inc. The market is
expected to witness lucrative growth during the forecast period owing to
technological advancements in wearable injectors coupled with rising demand for
round-the-clock monitoring. The paradigm shift towards self-administration of
injectable is expected to drive the market during the forecast period. In
addition, increasing awareness and rising adoption of wearable injectors are
expected to assist in growth.
Request Sample Copy of Report- https://www.radiantinsights.com/research/wearable-injectors-market/request-sample?utm_source=Pr&utm_campaign=Nikkhhil
Technological
advancements in wearable injectors, such as Bluetooth integrated wearable
injectors, enable sending alerts to patients, such as injection reminders, and
provide patients access to data regarding their therapy regime. Also, optional
smart functionality provides connectivity to the healthcare network. Some of
these devices have buttons that are accessible through clothing, and others
prevent accidental activation. They also have audio and visual status
indicators or signals. Patients can self-administer drugs subcutaneously in
less time and with minimal effort as compared to intravenous or other routes.
Patients are not required to visit any healthcare provider for administration.
Prevalence
of lifestyle-associated diseases, such as diabetes and hypertension, is
expected to increase during the forecast period. These diseases demand
round-the-clock monitoring of various physiological parameters, such as blood
pressure and blood sugar levels. Thus, integration of healthcare data with
wearable injectors, which gets forwarded to physicians or doctors giving them
real-time access with minimal errors, is expected to boost the wearable
injectors market.
Further key findings from the study
suggest:
•
The on-body segment held lucrative market share in 2016, owing to growing
preference of patients for adhesive patches that release the drug easily and
can be worn on the skin
•
The motor-driven segment is expected to register the highest growth over the
forecast period owing to increasing demand from hospitals, clinics, retail
chain stores, and pharmacies
•
The oncology segment is expected to gain the largest market share due to
increasing incidence of cancer worldwide
•
North America is expected to dominate the wearable injectors market over the
forecast period due to rising demand for innovative Information Technology (IT)
solutions to streamline workflow and increasing regulatory requirements to
ensure patient safety
•
Some of the key players in wearable injectors market are Becton, Dickinson and
Company; Johnson & Johnson Services, Inc.; F. Hoffmann-La Roche Ltd.;
Unilife Corporation; SteadyMed Therapeutics, Inc.; Amgen, Inc.; Insulet
Corporation; Enable Injections; West Pharmaceutical Services, Inc.; and CeQur
SA
View Full Report at- https://www.radiantinsights.com/research/wearable-injectors-market?utm_source=Pr&utm_campaign=Nikkhhil
About Us
Radiant
Insights is a market research and consulting company offering syndicated
research studies, customized reports, and consulting services. Our market
research studies are designed to facilitate strategic decision making, on the
basis of extensive and in-depth quantitative information, supported by
extensive analysis and industry insights. Using a patented and robust research
methodology, we publish exhaustive research reports covering a host of
industries such as Technology, Chemicals, Materials, and Energy. Radiant
Insights has a strong base of analysts, consultants and domain experts, with
global experience helping us deliver excellence in all research projects we
undertake
Contact Us
Michelle
Thoras
Corporate
Sales Specialist, USA
Radiant
Insights, Inc
201
Spear Street 1100, Suite 3036, San Francisco, CA 94105, United States
Tel:
1-415-349-0054
Toll
Free: 1-888-928-9744
No comments:
Post a Comment